Top

Tumor Biology

Published in:

01-10-2016 | Original Article

Ganoderic acid targeting multiple receptors in cancer: in silico and in vitro study

Published in: Tumor Biology | Issue 10/2016

Title: Ganoderic acid targeting multiple receptors in cancer: in silico and in vitro study
Publication date: 01-10-2016
Published in: Tumor Biology / Issue 10/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-016-5291-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 10/2016

CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients

The interaction of Wnt-11 and signalling cascades in prostate cancer

Erratum to: TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer

Curcumin inhibits cell growth and induces cell apoptosis through upregulation of miR-33b in gastric cancer

Polymorphisms in DNA repair genes in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome

miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes

Keynote webinar | Spotlight on antibody–drug conjugates in cancer